Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 18, 2020

View Archived Issues

Celiac model captures gluten, genetics and gut reactions

Autophagy helps repair lung injury

Strengthening lysosomes could head Parkinson's off at the pass

Neuropore receives a grant to developTLR2 agonist for ALS

PYC receives NHMRC grant to identify new antisense drugs

Arcus initiates phase II study of zimberelimab monotherapy and with immunotherapies in NSCLC

ModraDoc006 shows promising efficacy and safety in phase I study in mCRPC

Pfizer presents first interim analysis data from TALAPRO-1 study of talazoparib

Phase I data for guadecitabine plus cisplatin in patients with platinum-refractory GCT

Roche, Genentech describe new MEKKK1 inhibitors

New tachykinin NK1 receptor antagonists identified at XW Laboratories

Inventiva discloses new PPAR agonists

Mutabilis patents bacterial beta-lactamase inhibitors

Preclinical data presented for SIG-007 in models of Fabry disease

PD-1/PD-L1 interaction inhibitors described by Shanghai Ennova Biopharmaceutical

Progranulin gene therapy has therapeutic effects in knockout model

KRT5 and KRT20 found to predict treatment response in patients with muscle-invasive bladder cancer

PSA declines seen with 225Ac-DOTA-J591 in mCRPC trial

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...